What adjuvant endocrine therapy would you recommend for a male patient with HR positive breast cancer and history of DVT/PE?

For a male patient with Breast Cancer, with a history of DVT/PE, I would prefer to avoid tamoxifen and would recommend an aromatase inhibitor (AI) with a gonadotropin-releasing hormone (GNRH) analog for 5 years.

The rationale of adding GNRH analog (e.g goserelin) is that the use of AIs will lead to a...